Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab

Wu, M., Fulgenzi, C. A. M., D’Alessio, A., Cortellini, A., Celsa, C., Manfredi, G. F., Stefanini, B., Wu, Y. L., Huang, Y.-H., Saeed, A., Pirozzi, A., Pressiani, T., Rimassa, L., Schoenlein, M., Schulze, K., von Felden, J., Mohamed, Y., Kaseb, A. O., Vogel, A., … Ang, C. (2025). Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab. JHEP Reports, 7(2), 101232. https://doi.org/10.1016/j.jhepr.2024.101232
Authors:
Meng Wu
Claudia A M Fulgenzi
Antonio D'Alessio
Alessio Cortellini
Ciro Celsa
Giulia F Manfredi
Bernardo Stefanini
Y Linda Wu
Yi-Hsiang Huang
Anwaar Saeed
Angelo Pirozzi
Tiziana Pressiani
Lorenza Rimassa
Martin Schoenlein
Kornelius Schulze
Johann von Felden
Yehia Mohamed
Ahmed O Kaseb
Arndt Vogel
Natascha Roehlen
Marianna Silletta
Naoshi Nishida
Masatoshi Kudo
Caterina Vivaldi
Lorenz Balcar
Bernhard Scheiner
Matthias Pinter
Amit G Singal
Joshua Glover
Susanna Ulahannan
Fredrich Foerster
Arndt Weinmann
Peter R Galle
Neehar D Parikh
Wei-Fan Hsu
Alessandro Parisi
Hong Jae Chon
David J Pinato
Celina Ang
Affiliated Authors:
Y Linda Wu
Columbia Affiliation:
Author Keywords:
hepatocellular carcinoma
atezolizumab
bevacizumab
second-line therapy
immune checkpoint inhibitors
immunotherapy
tyrosine kinase inhibitors
elink
Publication Type:
Article
Unique ID:
10.1016/j.jhepr.2024.101232
PMID:
39877031
DOI:
10.1016/j.jhepr.2024.101232
Journal:
JHEP Reports
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: